Vestas - Court approval of proposed settlement of US class action

Udgivet den 09-12-2014  |  kl. 20:31  |  

Aarhus, Denmark, 2014-12-09 20:31 CET (GLOBE NEWSWIRE) --

On 21 March 2011, Vestas disclosed that a lawsuit had been filed as a class action in a US court against Vestas Wind Systems A/S, its US subsidiary and certain officers and directors, ref. company announcement No. 8/2011 of 21 March 2011. In company announcement No. 25/2014 of 26 June 2014, Vestas announced that a conditional settlement of this dispute had been reached. As part of this settlement, the claims against the individual officers and directors were also dropped.

The settlement consists of a cash payment of USD 5m to the plaintiffs, and this amount will be paid in its entirety by Vestas’ insurer.

The United States District Court, Portland Division, has now approved the proposed settlement. This settlement will become final 30 days after the court approval unless the approval is appealed. 

One of the allegations raised by the plaintiffs was that Vestas’ share price had been inflated during the class period due to misstatements and omissions in relation to the company’s accounting for supply-and-installation contracts under IFRIC 15. Vestas expressly denies all allegations in the lawsuit and maintains that its disclosures to the public were appropriate at all times. Vestas therefore does not concede any wrongdoing or liability in relation to the claims raised against it. Nevertheless, it has been deemed desirable for Vestas to resolve the claims in order to end the substantial expenses, burdens and uncertainties associated with continued litigation in the USA. 

The settlement relates only to purchases of American Depositary Receipts and ordinary shares bought in US domestic transactions during the US class period commencing 11 February 2009 and ending 9 February 2012. The settlement does not affect other transactions or the lawsuit that was filed in the City Court of Aarhus by 87 shareholders in August 2013, ref. company announcement No. 35/2013 of 16 August 2013.

   

Contact details
Vestas Wind Systems A/S, Denmark
Hans Martin Smith, Senior Vice President, Investor Relations
Tel.: +45 9730 8209

Vedhæftede filer:

141209_CA_UK_44.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed